Activation of T cell checkpoint pathways during beta-cell antigen presentation by engineered dendritic cells promotes protection of non-obese diabetic mice from type 1 diabetes
R. R. Gudi, N. Perez, S. Karumuthil-Melethil, G. Li, C. Vasu
Engineered dendritic cells expressing checkpoint receptor ligands reduce insulitis and hyperglycemia in NOD mice by enhancing regulatory T cell responses and suppressing effector T cell function.
bioRxiv · Aug 8, 2021 · PreprintImmunology